PCN-224 Nanoparticle/Polyacrylonitrile Nanofiber Membrane for Light-Driven Bacterial Inactivation

Xiaolin Nie1, Shuanglin Wu1, Tanveer Hussain2

  • 1Key Laboratory of Eco-Textiles, Ministry of Education, Jiangnan University, Wuxi 214122, China.

Insights

This study developed a novel nanofiber membrane embedding porphyrin-MOF nanoparticles for antibacterial photodynamic inactivation (aPDI). The material effectively eliminates E. coli and S. aureus, offering a promising solution for drug-resistant infections.

Area of Science:

  • Materials Science
  • Biotechnology
  • Nanotechnology

Background:

  • Rising antimicrobial resistance and pathogen spread necessitate innovative therapeutic strategies.
  • Photodynamic antibacterial inactivation (aPDI) presents a promising approach to combat infectious diseases.

Purpose of the Study:

  • To synthesize and evaluate a novel nanofiber membrane incorporating porphyrin-embedded metal-organic framework (MOF) material (PCN-224) for aPDI.
  • To assess the antibacterial efficacy and biocompatibility of the developed PAN-PCN nanofiber membrane.

Main Methods:

  • Synthesis of porphyrin-embedded MOF material (PCN-224).
  • Embedding PCN-224 nanoparticles into polyacrylonitrile (PAN) nanofibers via electrospinning to create PAN-PCN nanofiber membranes.
  • Antibacterial photodynamic inactivation (aPDI) assays against E. coli and S. aureus.
  • Mechanism study focusing on singlet oxygen generation.
  • MTT assay to evaluate biocompatibility.

Main Results:

  • The PAN-PCN nanofiber membrane demonstrated significant bacterial elimination: 3.00 log units for E. coli and 4.70 log units for S. aureus under illumination.
  • Singlet oxygen (1O2) was identified as the primary mechanism for bacterial inactivation.
  • The nanofiber membranes exhibited good biocompatibility in the dark, with cell survival rates exceeding 85%.

Conclusions:

  • The developed PAN-PCN nanofiber membrane effectively utilizes aPDI for bacterial inactivation.
  • This material offers a stable, recyclable, and biocompatible platform for combating drug-resistant pathogens.
  • The study highlights the potential of aPDI-enhanced nanofibers as a novel strategy against infectious diseases.